Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults

Neurology

Volumn 50, Issue 2, 1998, Pages 374-379

  Prince, Martin ^a   Rabe Hesketh, Sophia ^a   Brennan, Patrick ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; ANTIRHEUMATIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; THIAZIDE DIURETIC AGENT;

AGED; ARTHRITIS; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031910898     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.2.374     Document Type: Article

References (35)

1. Breitner JC. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol Aging 1996;17:789-794.
2. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and AJzheimer disease [letter]. Lancet 1990;335:1037.
3. Myllykangas Luosujarvi R, Isomaki H. Alzheimer's disease and rheumatoid arthritis [letter]. Br J Rheumatol 1994;33: 501-502.
4. Jenkinson ML, Bliss MR, Brain AT, Scott DL. Rheumatoid arthritis and senile dementia of the Alzheimer's type [letter]. Br J Rheumatol 1989;28:86-88.
5. Li G, Shen YC, Li YT, Chen CH, Zhau YW, Silverman JM. A case-control study of Alzheimer's disease in China. Neurology 1992;42:1481-1488.
6. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990;40: 1698-1707.
7. The Canadian Study of Health and Aging. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
8. Breteler MM, van Duijn CM, Chandra V, et al. Medical history and the risk of Alzheimer's disease: a collaborative reanalysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20(suppl 2):S36-S42.
9. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol Berl 1989;77:569-575.
10. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989;107:341-346.
11. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992;42: 447-449.
12. Henderson AS, Jorm AF, Korten AE, et al. Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types. Psychol Med 1992; 22:429-436.
13. Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psych 1994;36:854-856.
14. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995;45:1441-1445.
15. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-232.
16. Breitner JC, Welsh KA, Helms MJ, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16: 523-530.
17. Rogers J, Kirby LC, Hempelman SR, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993;43: 1609-1611.
18. Beard CM, Kokmen E, Kurland LT. Rheumatoid arthritis and susceptibility to Alzheimer's disease [letter]. Lancet 1991; 337:1426.
19. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984;15:335-341.
20. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-774.
21. Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 1994; 151:1105-1113.
22. Henderson VW, Paganini Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994;51:896-900.
23. McGeer PL, Harada N, Kimura H, McGeer EG, Schulzer M. Prevalence of dementia amongst elderly Japanese with leprosy: apparent effect of chronic drug therapy. Dementia 1992; 3:146-149.
24. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of Alzheimer's disease and duration of NSAJD use. Neurology 1997;48: 626-632.
25. Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM. Protective effect of chronic NSAID use on cognitive decline in older persons. J Am Geriatr Soc 1996;44:1025-1029.
26. Saag KG, Rubenstein LM, Chrischilles EA, Wallace RB. Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly. J Rheumatol 1995;22:2142-2147.
27. Fourrier A, Letenneur L, Begaud B, Dartigues JF. Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol 1996;49:1201
28. Prince M, Lewis G, Bird A, Blizard R, Mann A. A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychol Med 1996; 26:555-568.
29. MEG Working Party. MRC Research Council Trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
30. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. Br Med J 1996;312:801-805.
31. Bird AS, Macdonald AJD, Mann AH, Philpott MP. Preliminary experience with the SELF-CARE-D: a self-rating depression questionnaire for use with the elderly. Int J Geriatr Psych 1987;2:31-38.
32. Nelson H, O'Connell A. Dementia. The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 1978;14:234-244.
33. Inglis J. A Paired-Associate Learning Test for use with elderly psychiatric patients. J Mental Sci 1959;105:440-443.
34. Reltan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Motor Skills 1959;8: 271-276.
35. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measures in medical research. Br Med J 1990;300: 230-235.